Anemia
Links shared publicly online about this topic.
- 304total visits
Anemia
View full resource at kidshealth.org
Tags: Anemia, Disease and Condition, Stress Management
Most Recently Shared on May 10, 2011 at 3:20 am By:
Also Shared By:
sickel cell disease Ppt Powerpoint Presentation slides-Medical Slideshow Sickle Cell Anemia SCA is an inherited disease of the red blood cells.You
slideworld.org — “Powerpoint sickel cell disease Slides by anupam kumar Sickle Cell Anemia SCA is an inherited disease of the red blood cells.You Download Free Medical Powerpoint Presentations” View full resource at slideworld.org
Most Recently Shared on March 29, 2012 at 3:52 pm By:
Medical Templates Health Organization
sickel cell disease: PowerPoint Presentation on sickel cell disease http://t.co/ojY4yznA
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 28, 2012 at 7:47 pm By:
Amgen Loses Monopoly on Drug for Dialysis Patients - http://t.co/O6kMuGDy #pharma
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 28, 2012 at 6:19 pm By:
Daniel Kraft Doctor, Pediatrician, Internist, Health Executive, and Physician
NYTimes: F.D.A. Approves New Anemia Drug http://t.co/WJKYbgWZ
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 28, 2012 at 10:51 am By:
Kent Bottles, MD Doctor, Pathologist, and Physician
Amgen Loses Monopoly on Drug for Dialysis Patients: http://t.co/AEiXXAfM
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 28, 2012 at 1:16 am By:
FDA Approves New Anemia Drug http://t.co/Auh0ppSW
Affymax and Takeda Announce FDA Approval of Omontys (peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis
drugs.com — “Omontys (peginesatide) is used to treat anemia due to Chronic Kidney Disease. Includes Omontys side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 27, 2012 at 11:41 pm By:
FDA Approves Omontys (peginesatide) for the Treatment of Anemia Due to Chronic Kidney Disease - http://t.co/rluIf9fp
Affymax and Takeda Announce FDA Approval of Omontys (peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis
drugs.com — “Omontys (peginesatide) is used to treat anemia due to Chronic Kidney Disease. Includes Omontys side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 27, 2012 at 11:06 pm By:
Drugs and Devices OW OW Health
Affymax and Takeda Announce FDA Approval of Omontys (peginesatide) Injection for the Treatment of Anemia D... http://t.co/O4BqcAm5 #drug
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 27, 2012 at 7:30 pm By:
HealthTrendster Health Executive
F.D.A. Approves New Anemia Drug - A new anemia drug provides a less expensive alternative for dialysis patients and ... http://t.co/9YfRzcyE
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The F.D.A. approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 27, 2012 at 7:15 pm By:
F.D.A. Approves New Anemia Drug: A new anemia drug provides a less expensive alternative for dialysis patients a... http://t.co/4Ku4AF4F
Affymax Wins Approval of Drug for Anemic Kidney Patients - Businessweek
businessweek.com — “Affymax Inc. (AFFY) won U.S. approval for Omontys, a competitor to Amgen Inc. (AMGN)’s anemia treatments that have been the only options for patients with loss of kidney function for more than 20 years.” View full resource at businessweek.com
Most Recently Shared on March 27, 2012 at 7:11 pm By:
Affymax Wins Approval of Drug for Anemic Kidney Patients http://t.co/4PxD50uz
Affymax and Takeda Announce FDA Approval of OMONTYS® (Peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Affymax, Inc. and Takeda Pharmaceutical Company Limited , today announced that the U.S. Food and Drug Administration approved OMONTYS® Injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis.” View full resource at finance.yahoo.com
Most Recently Shared on March 27, 2012 at 6:44 pm By:
Luke Timmerman Health Communicator
Affymax conf call coming up fast, 2:45 pm ET/11:45 am PT. http://t.co/8TpSAOyY
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 27, 2012 at 6:27 pm By:
Anas Younes, M.D. Physician, Doctor, Internist, and Oncologist
F.D.A. Approves Affymax's new drug Omontys for anemic patients receiving kidney dialysis... http://t.co/2o68syVQ
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 27, 2012 at 6:21 pm By:
NYT: F.D.A. Approves New Anemia Drug http://t.co/z3CAgl33
Affymax, Takeda Win Approval of Anemia Drug to Challenge Amgen | Xconomy
xconomy.com — “Affymax completed its surprising comeback today, as it won FDA clearance for its first marketed drug, a product for anemia that will be the first to rival a” View full resource at xconomy.com
Most Recently Shared on March 27, 2012 at 4:58 pm By:
Luke Timmerman Health Communicator
Update to Affymax FDA approval story, with comments from CEO John Orwin. Conf call coming later today. http://t.co/bG1ow9T0
Dr. Carols Naturally Healthy Pets Blog
carolonpets.com — “Dr. Carols Naturally Healthy Pets Blog” View full resource at carolonpets.com
Most Recently Shared on March 27, 2012 at 10:42 am By:
American Pet Institute, a non profit public foundation for animal welfare and PAAWS, Pet Anti-Aging Wellness Society. Dr. Carol has pioneered the exploration of new therapies for the treatment and prevention of age-related degenerative disease, as well as promotion of optimum health and performance for pets.
Dr. Carol is the author of international bestsellers Naturally Healthy Dogs and Naturally Healthy Cats. European book sales records topped 200,000 copies with translation into 12 different languages.
Dr. Carol has been featured in USA Today, USA Weekend, The Los Angeles Times and the New York Daily News. She is the author of more than 200 articles in veterinary journals and popular magazines including “Trends”, the highly respected journal of the American Animal Hospital Association, DVM Magazine, Dog Fancy, Dog World, Cat Fancy, Fox Business, Puppies USA, Groomer to Groomer, Icelandic Horse and Travel, and Equine Athlete. Her editorial contributions also include In Style Magazine, Womans World and Icon Magazine, as well as Fit Magazine and The National Enquirer.
Dr. Carol earned her B.S. degree from John Carroll University where she graduated summa cum laude. She received her D.V.M. degree with honors from Ohio State University College of Veterinary Medicine and has been in private clinical practice for over 20 years. Currently, she devotes much of her time to the research and development of advanced biosciences for the benefit of animal health and welfare.
For more information and important updates on anti-aging medicine and natural longevity for pets, visitDr. Carol’s official web site at www.CarolOnPets.com or call her toll free at 1-866-372-2765 (1-866-DR-CAROL)." /> Dr Carol Osborne, DVM Active Health Library, Doctor, and Veterinarian
Advertisement
KidsHealth.org
@KidsHealthBaby
About #Anemia http://ow.ly/4QPv7
1 year ago...